Ivermectin & the Microbiome: Dr. Sabine Hazan’s Groundbreaking Testimony on COVID-19

In a compelling testimony, Dr. Sabine Hazan, a leading gastroenterologist and microbiome expert, shared profound insights from her frontline COVID-19 research. By analyzing patient stool samples, Dr. Hazan discovered that severe COVID-19 patients lacked a critical gut bacterium—Bifidobacterium—while those heavily exposed but never infected had it in abundance.

Bifidobacterium is a cornerstone of immunity, central to the trillion-dollar probiotic industry and abundant in newborns, explaining their early resilience to COVID-19. Aging, however, depletes this vital microbe, increasing vulnerability in older populations. Dr. Hazan’s team published these findings in their paper, The Lost Microbes of COVID-19, after an eight-month effort.

Her research revealed that Vitamin C boosts Bifidobacterium levels, supporting its role in fighting viral infections like the common cold—a practice many rely on. More strikingly, Dr. Hazan observed that Ivermectin, a drug derived from a bacterium closely related to Bifidobacterium, rapidly increased this microbe in patients within 24 hours. Patients treated with Ivermectin showed improved oxygen saturation, prompting Dr. Hazan to hypothesize a link.

Her Ivermectin hypothesis became the most-read of the pandemic, sparking global discussion. Yet, after eight months, it was controversially retracted. Dr. Hazan passionately argues that silencing hypotheses stifles science itself. “When we cannot make a hypothesis, this is not science,” she declared.

Dr. Hazan’s work highlights the gut’s critical role in immunity and raises bold questions about health and disease prevention. Could nurturing our microbiome be key to resilience?